2024 HCPCS Code G9585
Patient not evaluated for risk of misuse of opiates by using a brief validated instrument (e.g., opioid risk tool, soapp-r) or patient not interviewed at least once during opioid therapy
TAGS: evaluated using interviewed validated therapy least during patient opiates instrument brief misuse opioid
| Notice | HCPCS G9585 terminated on December 31, 2021. |
| Short Description | No eval opi use instr/intv |
| HCPCS Coverage Code | C - Carrier judgment |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Action Effective Date | January 01, 2022 |
| HCPCS Code Added Date | January 01, 2016 |
| HCPCS Pricing Indicator Code | 00 - Service not separately priced by part B (e.G., services not covered, bundled, used by part a only, etc.) |
| HCPCS Multiple Pricing Indicator Code | 9 - Not applicable as HCPCS not priced separately by part B (pricing indicator is 00) or value is not established (pricing indicator is '99') |
| HCPCS Coverage Issues Manual Reference Section Number | |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Anesthesia Base Unit Quantity | 0 |
Check Similar HCPCS Codes
- G9004 - Mccd, risk adj lo, initial
- G9005 - Mccd, risk adj, maintenance
- G9006 - Mccd, home monitoring
- G9007 - Mccd, sch team conf
- G9008 - Mccd,phys coor-care ovrsght
- G9009 - Mccd, risk adj, level 3
- G9010 - Mccd, risk adj, level 4
- G9011 - Mccd, risk adj, level 5
- G9012 - Other specified case mgmt
- G9013 - Esrd demo bundle level i
- G9014 - Esrd demo bundle-level ii
- G9016 - Demo-smoking cessation coun
- G9017 - Amantadine hcl 100mg oral
- G9018 - Zanamivir,inhalation pwd 10m
- G9019 - Oseltamivir phosphate 75mg
- G9020 - Rimantadine hcl 100mg oral
- G9033 - Amantadine hcl oral brand
- G9034 - Zanamivir, inh pwdr, brand
- G9035 - Oseltamivir phosp, brand
- G9036 - Rimantadine hcl, brand